Mesoporous silica- and silicon-based materials ... - Helda - Helsinki.fi

Takeuchi, H., Nagira, S., Yamamoto, H., Kawashima, Y., 2004. Solid dispersion particles of
tolbutamide prepared with fine silica particles by the spray-drying method. Powder Technol. 141,
187-195.
Takeuchi, H., Nagira, S., Yamamoto, H., Kawashima, Y., 2005. Solid dispersion particles of
amorphous indomethacin with fine porous silica particles by using spray-drying method. Int. J.
Pharm. 293, 155-164.
Tanaka, T., Godin, B., Bhavane, R., Nieves-Alicea, R., Gu, J., Liu, X., Chiappini, C., Fakhoury,
J.R., Amra, S., Ewing, A., Li, Q., Fidler, I.J., Ferrari, M., 2010a. In vivo evaluation of safety of
nanoporous silicon carriers following single and multiple dose intravenous administrations in
mice. Int. J. Pharm. 402, 190-197.
Tanaka, T., Mangala, L.S., Vivas-Mejia, P.E., Nieves-Alicea, R., Mann, A.P., Mora, E., Han, H.-
D., Shahzad, M.M.K., Liu, X., Bhavane, R., Gu, J., Fakhoury, J.R., Chiappini, C., Lu, C., Matsuo,
K., Godin, B., Stone, R.L., Nick, A.M., Lopez-Berestein, G., Sood, A.K., Ferrari, M., 2010b.
Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res. 70, 3687 -
3696.
Tanev, P.T., Pinnavaia, T.J., 1995. A neutral templating route to mesoporous molecular sieves.
Science 267, 865 -867.
Tang, X. (C.), Pikal, M.J., 2004. Design of freeze-drying processes for pharmaceuticals: Practical
advice. Pharm. Res. 21, 191-200.
Tao, Z., Morrow, M.P., Asefa, T., Sharma, K.K., Duncan, C., Anan, A., Penefsky, H.S.,
Goodisman, J., Souid, A.-K., 2008. Mesoporous silica nanoparticles inhibit cellular respiration.
Nano Lett. 8, 1517-1526.
Tasciotti, E., Liu, X., Bhavane, R., Plant, K., Leonard, A.D., Price, B.K., Cheng, M.M.-C.,
Decuzzi, P., Tour, J.M., Robertson, F., Ferrari, M., 2008. Mesoporous silicon particles as a
multistage delivery system for imaging and therapeutic applications. Nat. Nano 3, 151-157.
Taylor, K.M.L., Kim, J.S., Rieter, W.J., An, H., Lin, W., Lin, W., 2008. Mesoporous silica
nanospheres as highly efficient MRI contrast agents. J. Am. Chem. Soc. 130, 2154-2155.
Thies, R., Kleinebudde, P., 1999. Melt pelletisation of a hygroscopic drug in a high shear mixer:
Part 1. Influence of process variables. Int. J. Pharm. 188, 131-143.
Thomas, M.J.K., Slipper, I., Walunj, A., Jain, A., Favretto, M.E., Kallinteri, P., Douroumis, D.,
2010. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. Int. J.
Pharm. 387, 272-277.
Tomita, M., Hayashi, M., Awazu, S., 1996. Absorption-enhancing mechanism of EDTA, caprate,
and decanoylcarnitine in Caco-2 cells. J. Pharm. Sci. 85, 608-611.
Tong, H.H.Y., Du, Z., Wang, G.N., Chan, H.M., Chang, Q., Lai, L.C.M., Chow, A.H.L., Zheng,
Y., 2011. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved
dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound. Int. J. Pharm.
404, 148-158.
60